Literature DB >> 20807887

TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a.

Christofer Diakos1, Sheng Zhong, Yuanyuan Xiao, Mi Zhou, Gisele M Vasconcelos, Gerd Krapf, Ru-Fang Yeh, Shichun Zheng, Michelle Kang, John K Wiencke, Maria S Pombo-de-Oliveira, Renate Panzer-Grümayer, Joseph L Wiemels.   

Abstract

There is increasing evidence that miRNA and transcription factors interact in an instructive fashion in normal and malignant hematopoiesis. We explored the impact of TEL-AML1 (ETV6-RUNX1), the most common fusion protein in childhood leukemia, on miRNA expression and the leukemic phenotype. Using RNA interference, miRNA expression arrays, and quantitative polymerase chain reaction, we identified miRNA-494 and miRNA-320a to be up-regulated upon TEL-AML1 silencing independently of TEL expression. Chromatin immunoprecipitation analysis identified miRNA-494 as a direct miRNA target of the fusion protein TEL-AML1. Using bioinformatic analysis as well as functional luciferase experiments, we demonstrate that survivin is a target of the 2 miRNAs. miRNA-494 and miRNA-320a were introduced to the cells by transfection and survivin expression determined by Western blot analysis. These miRNAs blocked survivin expression and resulted in apoptosis in a similar manner as TEL-AML1 silencing by itself; this silencing was also shown to be Dicer-dependent. miRNAs-494 and -320a are expressed at lower levels in TEL-AML1+ leukemias compared with immunophenotype-matched nonTEL-AML1 acute lymphoblastic leukemia subtypes, and within TEL-AML1+ leukemias their expression is correlated to survivin levels. In summary our data suggest that TEL-AML1 might exert its antiapoptotic action at least in part by suppressing miRNA-494 and miRNA-320a, lowering their expression causing enhanced survivin expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807887      PMCID: PMC3265147          DOI: 10.1182/blood-2009-02-206706

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

Review 1.  Role of Dicer in posttranscriptional RNA silencing.

Authors:  Lukasz Jaskiewicz; Witold Filipowicz
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

2.  Multilevel regulation of gene expression by microRNAs.

Authors:  Eugene V Makeyev; Tom Maniatis
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

3.  Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.

Authors:  Dengli Hong; Rajeev Gupta; Philip Ancliff; Ann Atzberger; John Brown; Shamit Soneji; Joanne Green; Sue Colman; Wanda Piacibello; Veronica Buckle; Shinobu Tsuzuki; Mel Greaves; Tariq Enver
Journal:  Science       Date:  2008-01-18       Impact factor: 47.728

4.  The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.

Authors:  Anthony M Ford; Chiara Palmi; Clara Bueno; Dengli Hong; Penny Cardus; Deborah Knight; Giovanni Cazzaniga; Tariq Enver; Mel Greaves
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

5.  Regulation of progenitor cell proliferation and granulocyte function by microRNA-223.

Authors:  Jonathan B Johnnidis; Marian H Harris; Robert T Wheeler; Sandra Stehling-Sun; Michael H Lam; Oktay Kirak; Thijn R Brummelkamp; Mark D Fleming; Fernando D Camargo
Journal:  Nature       Date:  2008-02-17       Impact factor: 49.962

Review 6.  MicroRNAs and cancer: profile, profile, profile.

Authors:  Elisa Barbarotto; Thomas D Schmittgen; George A Calin
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

7.  Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.

Authors:  J K Wiencke; S Zheng; Z Morrison; R-F Yeh
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

8.  Patterns of microRNA expression characterize stages of human B-cell differentiation.

Authors:  Jenny Zhang; Dereje D Jima; Cassandra Jacobs; Randy Fischer; Eva Gottwein; Grace Huang; Patricia L Lugar; Anand S Lagoo; David A Rizzieri; Daphne R Friedman; J Brice Weinberg; Peter E Lipsky; Sandeep S Dave
Journal:  Blood       Date:  2009-02-06       Impact factor: 22.113

9.  Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia.

Authors:  Anne Saumet; Guillaume Vetter; Manuella Bouttier; Elodie Portales-Casamar; Wyeth W Wasserman; Thomas Maurin; Bernard Mari; Pascal Barbry; Laurent Vallar; Evelyne Friederich; Khalil Arar; Bruno Cassinat; Christine Chomienne; Charles-Henri Lecellier
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

10.  Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.

Authors:  Zejuan Li; Jun Lu; Miao Sun; Shuangli Mi; Hao Zhang; Roger T Luo; Ping Chen; Yungui Wang; Ming Yan; Zhijian Qian; Mary Beth Neilly; Jie Jin; Yanming Zhang; Stefan K Bohlander; Dong-Er Zhang; Richard A Larson; Michelle M Le Beau; Michael J Thirman; Todd R Golub; Janet D Rowley; Jianjun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

View more
  29 in total

Review 1.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

Review 2.  MicroRNA regulation and therapeutic targeting of survivin in cancer.

Authors:  Jingcao Huang; Hui Lyu; Jianxiang Wang; Bolin Liu
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  miRNA-320 inhibits colitis-associated colorectal cancer by regulating the IL-6R/STAT3 pathway in mice.

Authors:  Meng-Yao Wu; Yu-Xin Luo; Wen-Xiu Jia; Dan-Dan Wang; Dong-Lei Sun; Jia Song; Jing Wang; Wei-Wei Niu; Xiao-Lan Zhang
Journal:  J Gastrointest Oncol       Date:  2022-04

4.  MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1.

Authors:  Zhuoan Cheng; Shaobo Qiu; Lin Jiang; Anle Zhang; Wenjing Bao; Ping Liu; Jianwen Liu
Journal:  J Clin Immunol       Date:  2012-11-30       Impact factor: 8.317

5.  miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.

Authors:  Na Li; Xiaosu Zhao; Lufei Wang; Shi Zhang; Manhua Cui; Jin He
Journal:  Tumour Biol       Date:  2015-12-22

6.  MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells.

Authors:  Y Xie; L A Tobin; J Camps; D Wangsa; J Yang; M Rao; E Witasp; K S Awad; N Yoo; T Ried; K F Kwong
Journal:  Oncogene       Date:  2012-06-25       Impact factor: 9.867

7.  MicroRNA-494 inhibits proliferation and metastasis of osteosarcoma through repressing insulin receptor substrate-1.

Authors:  Xiaodong Zhi; Kai Wu; Deshui Yu; Yansong Wang; Yang Yu; Peng Yan; Gang Lv
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 3.940

8.  Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes.

Authors:  Geula Hanin; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2011-10-05       Impact factor: 5.639

9.  A novel real-time PCR assay of microRNAs using S-Poly(T), a specific oligo(dT) reverse transcription primer with excellent sensitivity and specificity.

Authors:  Kang Kang; Xiaoying Zhang; Hongtao Liu; Zhiwei Wang; Jiasheng Zhong; Zhenting Huang; Xiao Peng; Yan Zeng; Yuna Wang; Yi Yang; Jun Luo; Deming Gou
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

10.  Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study.

Authors:  Qian Xu; Qi-Guan Dong; Li-Ping Sun; Cai-Yun He; Yuan Yuan
Journal:  BMC Clin Pathol       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.